QSAR-guided discovery of novel KRAS inhibitors for lung cancer therapy
{{output}}
Introduction: KRAS mutations are key oncogenic drivers in lung cancer, yet effective pharmacological targeting has remained a major challenge due to the protein's elusive and dynamic binding pockets. Computational modeling offer... ...
